Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Brighter AB (publ)
  6. News
  7. Summary
    BRIG   SE0004019545


SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Brighter : Actiste Mini Receives Telecommunication Approval in Qatar

06/18/2021 | 03:01am EDT

Brighter AB (Publ.) today announced that Qatari Communications Regulatory Authority has granted Actiste® Mini type approval for the radio transmission element in the device.

With this approval, telecommunication registration is completed for Actiste® Mini and the product is approved for telecom use in Qatar.

Brighter communicated earlier this year that the company signed a five-year distribution agreement with Al Danah Medical Company in Qatar regarding Brighter's pioneering product portfolio for diabetes management Actiste® ("Actiste Service").

"With Qatar's healthcare system being primarily state-run the outcome of the distribution agreement we communicated in February will largely depend on the Distributor's ability to win public tenders, but this approval is a significant milestone in the commercialization of the Actiste® portfolio," says Christer Trägårdh, acting CEO of Brighter AB.

Next step is to receive the same approval for Actiste® (with insulin injection) and to complete all remaining preparations including patient on-boarding and customer service setup.

For more information, please contact:

Investor Relations

Certified Adviser

Brighter's Certified Adviser is Eminova Fondkommission AB, +46 [0)8 - 684 211 10, adviser@eminova.se, www.eminova.se.

About Brighter AB (publ)
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to providing smarter care for chronic conditions. Our daily-care solutions are designed with a vision to facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers - aiming to improve quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. The Company's shares are listed on Nasdaq First North Growth Market/BRIG. https://brighter.se/



(c) 2021 Cision. All rights reserved., source Press Releases - English

All news about BRIGHTER AB (PUBL)
07/27BRIGHTER : enters into commercial collaboration agreement with VivBon AB in Swed..
07/27Brighter Enters into Commercial Collaboration Agreement with VivBon AB in Swe..
07/21BRIGHTER : Names New Interim CEO; Stock Up 25%
07/20BRIGHTER : appoints Erik Lissner as interim CEO
07/20Brighter AB Appoints Christer Trägårdh as Chairman of Board
07/20Brighter AB Announces Interim CEO Changes
07/12BRIGHTER : Subsidiary Nectarine Health Receives Approval to Release Nectarine He..
07/06BRIGHTER : carries out a private placement of SEK 5 million
07/01BRIGHTER : 01 Jul, 2021 Brighter's Actiste« Receives Telecommunication Approval ..
07/01BRIGHTER : Actiste« Receives Telecommunication Approval in Qatar
More news
Sales 2021 41,0 M 4,80 M 4,80 M
Net income 2021 -171 M -20,0 M -20,0 M
Net Debt 2021 135 M 15,8 M 15,8 M
P/E ratio 2021 -5,00x
Yield 2021 -
Capitalization 903 M 106 M 106 M
EV / Sales 2021 25,3x
EV / Sales 2022 5,01x
Nbr of Employees 89
Free-Float 81,3%
Duration : Period :
Brighter AB (publ) Technical Analysis Chart | BRIG | SE0004019545 | MarketScreener
Technical analysis trends BRIGHTER AB (PUBL)
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus -
Number of Analysts 1
Last Close Price 2,60 
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Erik Lissner Chief Executive Officer
Ann Zetterberg Littorin Chief Financial Officer
Christer Trńgňrdh Chairman
┼sa Hallin Dahlberg Head-Research & Development
Jan Ingvar Georg Stňlemark Director
Sector and Competitors